Company Overview and News
THE Court of Tax Appeals (CTA) has granted San Miguel Holdings Corp. (SMHC) a partial tax refund of P50.61 million for “excessive” taxes collected by the Bureau of Internal Revenue (BIR).
SMGBF FILIY SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E FDC SMGBY
THE infrastructure arm of tycoon Andrew L. Tan’s Alliance Global Group, Inc. (AGI) bagged the original proponent status (OPS) for its proposed P3-billion monorail project connecting Fort Bonifacio to the Guadalupe station of the Metro Rail Transit (MRT) Line 3.
FILIY JGSMY ALGGY RWM JGS MPI MPCFF MPCIY ALGGF FDC AGI JGSHF
THE Department of Transportation (DoTr) may grant within the next two weeks the original proponent status (OPS) to the consortium seeking to rehabilitate the Ninoy Aquino International Airport (NAIA).
JGSMY JGS MPCIY PXMFF GMQRY GMRINFRA 532754 FILIY PX ALGGY MWP MPI MPCFF ALGGF FDC AGI MWIDE PXMFY JGSHF
THE CONSORTIUM formed by some of the country’s conglomerates has submitted a revised proposal to rehabilitate the Ninoy Aquino International Airport (NAIA), cutting the project duration from 35 years to 15 years.
JGSMY JGS MPCIY GMQRY GMRINFRA 532754 FILIY ALGGY MWP MPI MPCFF ALGGF FDC AGI MWIDE JGSHF
A CONTRACT to operate and maintain (O&M) for 25 years an expanded Clark International Airport — designed to decongest the premier gateway in Metro Manila — has attracted several groups that sent representatives to a pre-bid conference in Bonifacio Global City, Taguig City on Monday.
MQBKY JGSMY SMCP1 JGS 5014 SMGBF SMC MPCFF MQG JGSHF MPCIY BC94 SMSN MCQEF SMGBY FILIY SMC2B SMC2A SMC2D SMC2C MPI SMC2F SMC2E MYPRY FDC SMSD
The bidding for the operation and maintenance of Clark International Airport in Pampanga province—seen as an alternative to Manila’s congested Ninoy Aquino International Airport—lured big names and one brewing issue, with an interested bidder seemingly disqualified at the onset.
FILIY MWP FDC GMRINFRA GMQRY MWIDE 532754
A FUTURE government will end up making the decision to designate a main international gateway airport for Metro Manila, the National Economic and Development Authority (NEDA) said, due to the long timelines for the airports under development around the nation’s capital.
JGSMY SMCP1 JGS MPCIY SMGBY SMGBF FILIY SMC2B SMC2A SMC SMC2D ALGGY SMC2C MWP MPI MPCFF SMC2F SMC2E ALGGF FDC AGI MWIDE JGSHF
KOREAN-LED Widus International Leisure, Inc., the operator of the Marriot hotel chain in Clark, Pampanga, is looking at expanding its hotel projects in the city to total to $1 billion in the next few years.
FILIY FVSMF MWP FDC GMRINFRA GMQRY FLI MWIDE 532754
Gotianun-led East West Bank plans to go back to the local capital market to support balance sheet expansion by the third quarter with an offering of P10 billion worth of shares to existing shareholders.
FILIY PSKXF FDC PHSXY PSE
UNIONBANK of the Philippines welcomed the move of the Bangko Sentral ng Pilipinas (BSP) to ease rules on the lending ceiling imposed on banks to accommodate financing for big-ticket infrastructure projects.
JGSMY JGS MPCIY AEV FILIY ALGGY ABTZY MPI MPCFF ALGGF FDC AGI JGSHF
SINGAPORE — President Rodrigo Duterte on Saturday invited foreign investors to the Philippines to create more jobs for his countrymen and assured them he would personally deal with corrupt officials who might extort money or make trouble for their businesses.
FILIY CEBUF CEBUY FDC S59 CEB SEGSY SEGSF
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
2018-06-18 - Asif
Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...
Silicon Investor Message Boards
This table lists all message boards related to PSE:FDC / Filinvest Development Corporation on message board site Silicon Investor.
|FDC : First Data Corp||HFDC HomeFed Corp. (OTC:BB)|
|Factual Data (FDCC)||CSCO MSPG FDC JVLN Net Articles, Reader Highlight TD|
|MSFDC - Microsoft/First Data Corp Joint Venture|